News Flash 3.2022
At the beginning of March, the Food and Drug Administration (FDA) approved Olaparib (Lynfarza) for the treatment of HER2 negative high-risk breast cancer patients with BRCA mutated germline, who have been treated with chemotherapy, before or after surgery. The approval is supported by results from a clinical trial in which 1,836 breast cancer patients meeting […]
MRI-Guided Radiotherapy in Prostate Cancer – 2.2022
Initial results from an ongoing study indicate that using MRI to guide precisely-focused high dose radiation treatment for prostate cancer, reduced side effects associated with the treatment. Advanced radiation technics like high-dose stereotactic body radiotherapy (SBRT) offer the opportunity to deliver high radiation doses to tumors, while sparing surrounding tissues. Computed tomography (CT) is often […]
World Health Organization’s Data (2021): Global Cancer Incidence and Mortality
According to World Health Organization (WHO) data published in 2021, there is a significant trend pointing towards a worldwide increase in the absolute number of cancer patients diagnosed each year, as well as in the numbers of cancer patients dying from the disease each year. It should be noted that this data reflects both […]
News Flash 12.2021
At the beginning of December, the Food and Drug Administration approved Pembrolizumab (Keytruda) – an immunotherapy drug – for adjuvant treatment of adult and pediatric patients (12 years of age and above) who were diagnosed with cutaneous melanoma without lymph node involvement (stage IIB or IIC), following complete resection of the tumor. The approval is […]
News Flash 11.2021
Several weeks ago, the Food and Drug Administration approved Atezolizumab (Tecentric) – a type of immunotherapy called an “immune checkpoint inhibitor” – for adjuvant treatment, following tumor resection and chemotherapy in patients with early stage (II-IIIA) non-small cell lung cancer, whose tumor cells express PD-L1≥1%. The approval was based on results from a clinical trial […]
News Flash 10.2021 – Covid-19 Vaccine in Cancer Patients
Covid-19 vaccine appears to have high efficacy in patients with cancer. Findings from five studies recently presented at the ESMO (European Society for Medical Oncology) Congress 2021, suggest that cancer patients respond to vaccination regardless of current oncology treatment, with a good safety profile. In 3,813 patients who participated in one of the studies, and […]
Cancer Treatment Breakthrough, 2018 – Genetic Engineering
During the last decade, the use of immunotherapy – a new treatment approach in the field of oncology – has shown very promising results.This approach is based on the idea that it is possible to fight cancer not only by using “external” technologies such as chemotherapeutic agents and/or radiotherapy, but also by using internal resources, […]
News Flash 8.2017 – Having a Baby after Breast Cancer Diagnosis
Findings from a retrospective study recently published confirm that pregnancy after breast cancer can be considered safe, since it does not raise the risk of recurrence and/or death. The study enrolled 1,207 young women diagnosed with early stage breast cancer who were treated in medical centers throughout Europe.Approximately one third of the women included in […]
News Flash 5.2017 – Trends and Innovations in the Field of Oncology, 2017
According to the WHO (World Health Organization) data, the absolute number of new cancer patients diagnosed annually all over the world, is going to increase by about 50% over the next two decades. However, it is important to note that when specifically referring to developed countries (e.g. the USA and Western Europe), this expected increase can be […]
News Flash 7.2016 – Research Results (UpToDate July 2016)
*IVF and risk of breast cancerIn a study of over 19,000 women undergoing IVF treatment between 1983 and 1995 and followed for a median of 21 years, the risk of breast cancer was similar to that of the general population.(However, it is a bit difficult to generalize these data among women undergoing contemporary IVF treatment, since […]